Online Simulation

And More

Top 25 Tags (all tags)

  1. algorithms
  2. carbon nanotubes
  3. circuits
  4. course lecture
  5. cyberinfrastructure
  6. devices
  7. education/outreach
  8. experiments
  9. material science
  10. molecular electronics
  11. nano/bio
  12. nanobio applications
  13. nano electro-mechanical systems
  14. nanoelectronics
  15. nanomedicine
  16. nanophotonics
  17. nano-transistors
  18. nanowires
  19. NEGF
  20. quantum dots
  21. research seminar
  22. SURI
  23. tutorial
  24. uIllinois
  25. uiuc

Other

Trouble Report

For immediate assistance browse through our support center. You can find answers to many questions in just a few minutes.

If still experiencing problems, send us a report.

Sending report ...

Contributors: View

Ross Weatherman

Contributor picture

Contributions 1 (detailed usage)
Affiliation Purdue University, West Lafayette
Web Site http://www.mcmp.purdue.edu/faculty/?uid=rossw
Biography

Ross Weatherman is currently an assistant professor in the Department
of Medicinal Chemistry and Molecular Pharmacology at Purdue
University in West Lafayette. He received his undergraduate degree
from Wabash College, majoring in chemistry. After graduating from
Wabash, he obtained his Ph.D. in organic chemistry from University of
Wisconsin at Madison where he worked on protein-neoglycopolymer
interactions. He then took a postdoctoral position sponsored by the
California Division of the American Cancer Society at University of
California-San Francisco. At UCSF, he started his current research
into studying the mechanisms of action of selective estrogen receptor
modulators and designing new drugs for the treatment and prevention
of breast cancer. His current research interests include the use of
steroid hormone drugs conjugates to nanoscale vectors to investigate
novel molecular modes of action and possible therapeutic applications
in different types of cancer.

Contributions

  1. Antiestrogenic Conjugates as New Breast Cancer Chemoprevention Agents

    This resource has a 6.2 Ranking

    Ranking is calculated from a formula comprised of user reviews and usage statistics. Learn more ›

    Usage Stats
    Last 12 Months: updated 01 Jun, 2008
    Users: 26
    Reviews & Citations
    Google/IEEE
    Avg. Review: 0.0 out of 5 stars
    Citations: 0

    26 users

    0 reviews (Review this)

    0 citations

    08 Mar. 2007 | Online Presentations | Contributor(s): Ross Weatherman

    Tamoxifen is the first drug specifically approved for the prevention of cancer and arguably the most successful anticancer drug of all time. Although millions of breast cancer patients have benefited from tamoxifen therapy, there are side effects that hinder the broad use of tamoxifen as a …